- Home
- PMD
as 12-20-2024 4:00pm EST
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | ACTON |
| Market Cap: | 13.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 58.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.64 - $3.95 | Next Earning Date: | 11-12-2024 |
| Revenue: | $20,258,000 | Revenue Growth: | -11.16% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Psychemedics Corporation (PMD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Powell Anderson Capital Partners LLC | PMD | 10% Owner | Dec 13 '24 | Buy | $1.91 | 159,700 | $305,439.00 | 614,406 | |
| Powell Anderson Capital Partners LLC | PMD | 10% Owner | Dec 10 '24 | Buy | $2.66 | 86,991 | $231,848.85 | 614,406 | |
| Kamin Peter | PMD | Director10% Owner | Dec 10 '24 | Sell | $2.35 | 320,708 | $753,663.80 | 1,499,710 | |
| Kamin Peter | PMD | Director10% Owner | Dec 3 '24 | Buy | $2.35 | 1,409,712 | $3,312,823.20 | 1,820,418 |
Latest Psychemedics Corporation News
PMD Breaking Stock News: Dive into PMD Ticker-Specific Updates for Smart Investing
Simply Wall St.
12 days ago
US Penny Stocks To Watch In December 2024
GlobeNewswire
19 days ago
Psychemedics Corporation Announces Reverse and Forward Stock Split
GlobeNewswire
a month ago
Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders
Simply Wall St.
a month ago
Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023)
Associated Press Finance
a month ago
Psychemedics: Q3 Earnings Snapshot
GlobeNewswire
a month ago
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
GlobeNewswire
3 months ago
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
GlobeNewswire
4 months ago
Psychemedics Corporation Launches New Ketamine Hair Testing Service
Compare PMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PMD Psychemedics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.